{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T16:30:22Z","timestamp":1793205022669,"version":"4.5.0"},"reference-count":194,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"am","delay-in-days":256,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["DMR-1933525"],"award-info":[{"award-number":["DMR-1933525"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204272"],"award-info":[{"award-number":["82204272"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["42276137"],"award-info":[{"award-number":["42276137"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Carbohydrate Polymers"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.carbpol.2024.122216","type":"journal-article","created":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T08:34:23Z","timestamp":1714552463000},"page":"122216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Quality control, safety assessment and preparation approaches of low molecular weight heparin"],"prefix":"10.1016","volume":"339","author":[{"given":"Yanlei","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunjie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Linhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan S.","family":"Dordick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.carbpol.2024.122216_bb0005","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.carbpol.2013.05.046","article-title":"Ultrasonic-assisted preparation of a low molecular weight heparin (LMWH) with anticoagulant activity","volume":"97","author":"Achour","year":"2013","journal-title":"Carbohydrate Polymers"},{"key":"10.1016\/j.carbpol.2024.122216_bb0010","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00216-013-7446-4","article-title":"Structural features of glycol-split low-molecular-weight heparins and their heparin lyase generated fragments","volume":"406","author":"Alekseeva","year":"2014","journal-title":"Analytical and Bioanalytical Chemistry"},{"key":"10.1016\/j.carbpol.2024.122216_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/10760296211052293","article-title":"General considerations for diversifying heparin drug products by improving the current heparin manufacturing process and reintroducing bovine sourced heparin to the US market","volume":"27","author":"Al-Hakim","year":"2021","journal-title":"Clinical and Applied Thrombosis\/Hemostasis"},{"issue":"10","key":"10.1016\/j.carbpol.2024.122216_bb0020","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1007\/s00228-022-03365-4","article-title":"Tinzaparin\u2014A review of its molecular profile, pharmacology, special properties, and clinical uses","volume":"78","author":"Amerali","year":"2022","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1016\/j.carbpol.2024.122216_bb0025","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.biologicals.2020.06.004","article-title":"Processing bovine intestinal mucosa to active heparin removes spiked BSE agent","volume":"67","author":"Andrews","year":"2020","journal-title":"Biologicals: Journal of the International Association of Biological Standardization"},{"issue":"21","key":"10.1016\/j.carbpol.2024.122216_bb2020","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1182\/blood-2016-11-709873","article-title":"Heparin-induced thrombocytopenia","volume":"129","author":"Arepally","year":"2017","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.carbpol.2024.122216_bb0030","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3390\/ph10030066","article-title":"Modernization of enoxaparin molecular weight determination using homogeneous standards","volume":"10","author":"Arnold","year":"2017","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.carbpol.2024.122216_bb0035","first-page":"129","article-title":"A collaborative study of heparins from different source","volume":"42","author":"Bangham","year":"1970","journal-title":"Bulletin of the World Health Organization"},{"key":"10.1016\/j.carbpol.2024.122216_bb0040","doi-asserted-by":"crossref","first-page":"10524","DOI":"10.3390\/ijms221910524","article-title":"Heparin and its derivatives: Challenges and advances in therapeutic biomolecules","volume":"22","author":"Banik","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.carbpol.2024.122216_bb0045","unstructured":"Barnett, W. E. (1982). Anticoagulant substances. US Patent, 4351938."},{"issue":"2","key":"10.1016\/j.carbpol.2024.122216_bb0050","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0731-7085(89)80086-X","article-title":"The anticoagulant activity of heparin: Measurement and relationship to chemical structure","volume":"7","author":"Barrowcliffe","year":"1989","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"key":"10.1016\/j.carbpol.2024.122216_bb0055","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/j.drudis.2020.09.011","article-title":"Advances in the preparation and synthesis of heparin and related products","volume":"25","author":"Baytas","year":"2020","journal-title":"Drug Discovery Today"},{"issue":"4","key":"10.1016\/j.carbpol.2024.122216_bb0060","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1021\/acs.jmedchem.0c02019","article-title":"Preparation of low molecular weight heparin from a remodeled bovine intestinal heparin","volume":"64","author":"Baytas","year":"2021","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.carbpol.2024.122216_bb0065","doi-asserted-by":"crossref","first-page":"6842","DOI":"10.1021\/acs.analchem.5b01181","article-title":"1H and 15N NMR characterization of the amine groups of heparan sulfate related glucosamine monosaccharides in aqueous solution","volume":"87","author":"Beecher","year":"2015","journal-title":"Analytical Chemistry"},{"key":"10.1016\/j.carbpol.2024.122216_bb0070","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1007\/s00216-015-9231-z","article-title":"Screening enoxaparin tetrasaccharide SEC fractions for 3-O-sulfo-N-sulfoglucosamine residues using [1H, 15N] HSQC NMR","volume":"408","author":"Beecher","year":"2016","journal-title":"Analytical Bioanalytical Chemistry"},{"key":"10.1016\/j.carbpol.2024.122216_bb0075","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00216-010-4187-5","article-title":"Development and qualification of a size exclusion chromatography coupled with multiangle light scattering method for molecular weight determination of unfractionated heparin","volume":"399","author":"Beirne","year":"2011","journal-title":"Analytical Bioanalytical Chemistry"},{"issue":"7","key":"10.1016\/j.carbpol.2024.122216_bb0080","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1177\/1076029616685430","article-title":"Characterization of PF4-heparin complexes by photo correlation spectroscopy and zeta potential","volume":"24","author":"Bertini","year":"2017","journal-title":"Clinical and Applied Thrombosis\/Hemostasis"},{"issue":"10","key":"10.1016\/j.carbpol.2024.122216_bb0085","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1055\/s-0040-1715460","article-title":"The anticoagulant and nonanticoagulant properties of heparin","volume":"120","author":"Beurskens","year":"2020","journal-title":"Thrombosis and Haemostasis"},{"issue":"10","key":"10.1016\/j.carbpol.2024.122216_bb0090","first-page":"806","article-title":"Preserving the original heparin structure of a novel low molecular weight heparin by gamma-irradiation","volume":"51","author":"Bisio","year":"2001","journal-title":"Arzneimittel-Forschung"},{"key":"10.1016\/j.carbpol.2024.122216_bb0095","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.3390\/molecules22071051","article-title":"Structural characterization of the low-molecular-weight heparin dalteparin by combining different analytical strategies","volume":"22","author":"Bisio","year":"2017","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.carbpol.2024.122216_bb0100","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1160\/TH09-02-0081","article-title":"Structural features of low-molecular-weight heparins affecting their affinity to antithrombin","volume":"102","author":"Bisio","year":"2009","journal-title":"Thromosis and Harmostasis"},{"issue":"3","key":"10.1016\/j.carbpol.2024.122216_bb0105","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF00421226","article-title":"Mechanism of the anticoagulant action of heparin","volume":"48","author":"Bj\u00f6rk","year":"1982","journal-title":"Molecular and Cellular Biochemistry"},{"key":"10.1016\/j.carbpol.2024.122216_bb2000","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/nchembio.1956","article-title":"Functional and structural characterization of a heparanase","volume":"11","author":"Bohlmann","year":"2015","journal-title":"Nature Chemical Biology"},{"issue":"11","key":"10.1016\/j.carbpol.2024.122216_bb0110","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1111\/bcp.14081","article-title":"Biosimilars of low molecular weight heparins: Relevant background information for your drug formulary","volume":"85","author":"Brouwers","year":"2019","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"7","key":"10.1016\/j.carbpol.2024.122216_bb0115","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1039\/C8OB02756K","article-title":"Using automated glycan assembly (AGA) for the practical synthesis of heparan sulfate oligosaccharide precursors","volume":"17","author":"Budhadev","year":"2019","journal-title":"Organic & Biomolecular Chemistry"},{"key":"10.1016\/j.carbpol.2024.122216_bb0120","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1021\/ol500738g","article-title":"Fluorous-assisted chemoenzymatic synthesis of heparan sulfate oligosaccharides","volume":"16","author":"Cai","year":"2014","journal-title":"Organic Letters"},{"key":"10.1016\/j.carbpol.2024.122216_bb0125","first-page":"62","article-title":"Heparin structure","volume":"20","author":"Casu","year":"1990","journal-title":"Haemostasis"},{"key":"10.1016\/j.carbpol.2024.122216_bb0130","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.carres.2014.06.023","article-title":"Re-visiting the structure of heparin","volume":"403","author":"Casu","year":"2015","journal-title":"Carbohydrate Research"},{"issue":"37","key":"10.1016\/j.carbpol.2024.122216_bb0135","doi-asserted-by":"crossref","first-page":"10034","DOI":"10.1002\/ange.201404154","article-title":"Synthesis of the heparin-based anticoagulant drug Fondaparinux","volume":"126","author":"Chang","year":"2014","journal-title":"Angewandte Chemie"},{"key":"10.1016\/j.carbpol.2024.122216_bb0140","doi-asserted-by":"crossref","DOI":"10.1177\/1076029619840701","article-title":"Comparison of low-molecular-weight heparins prepared from ovine heparins with enoxaparin","volume":"25","author":"Chen","year":"2019","journal-title":"Clinical and Applied Thrombosis\/Hemostasis"},{"key":"10.1016\/j.carbpol.2024.122216_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2021.462049","article-title":"Comprehensive analysis of heparinase derived heparin-products using two-dimensional liquid chromatography coupled with mass spectrometry","volume":"1643","author":"Chen","year":"2021","journal-title":"Journal of Chromatography A"},{"key":"10.1016\/j.carbpol.2024.122216_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.114616","article-title":"Analysis of heparinase derived LMWH products using a MHC 2D LC system linked to Q-TOF MS","volume":"212","author":"Chen","year":"2022","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"key":"10.1016\/j.carbpol.2024.122216_bb0155","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.carbpol.2016.09.081","article-title":"Quantitative analysis of the major linkage region tetrasaccharides in heparin","volume":"157","author":"Chen","year":"2017","journal-title":"Carbohydrate Polymers"},{"issue":"4","key":"10.1016\/j.carbpol.2024.122216_bb0160","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.xphs.2016.11.023","article-title":"Structural analysis of heparin-derived 3-O-sulfated tetrasaccharides: Antithrombin binding site variants","volume":"106","author":"Chen","year":"2017","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"5","key":"10.1016\/j.carbpol.2024.122216_bb0165","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.xphs.2018.01.008","article-title":"Antithrombin III-binding site analysis of low-molecular-weight heparin fractions","volume":"107","author":"Chen","year":"2018","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"6","key":"10.1016\/j.carbpol.2024.122216_bb0170","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1074\/mcp.M114.045856","article-title":"GAG-ID: Heparan sulfate (HS) and heparin glycosaminoglycan high-throughput identification software","volume":"14","author":"Chiu","year":"2015","journal-title":"Molecular & Cellular Proteomics"},{"issue":"14","key":"10.1016\/j.carbpol.2024.122216_bb0605","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa1014475","article-title":"Dalteparin versus unfractionated heparin in critically ill patients","volume":"364","author":"Cook","year":"2011","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.carbpol.2024.122216_bb2005","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/bs.pmbts.2019.02.003","article-title":"Low molecular weight heparins and their clinical applications","volume":"163","author":"Cui","year":"2019","journal-title":"Progress in Molecular Biology and Translational Science"},{"issue":"4","key":"10.1016\/j.carbpol.2024.122216_bb0175","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2165\/00002512-199710040-00006","article-title":"Nadroparin calcium. A review of its pharmacology and clinical use in the prevention and treatment of thromboembolic disorders","volume":"10","author":"Davis","year":"1997","journal-title":"Drugs & Aging"},{"issue":"12","key":"10.1016\/j.carbpol.2024.122216_bb0180","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1039\/D1CY02061G","article-title":"Heparosan oligosaccharide synthesis using engineered single-function glycosyltransferases","volume":"12","author":"Deng","year":"2022","journal-title":"Catalysis Science & Technology"},{"key":"10.1016\/j.carbpol.2024.122216_bb0185","doi-asserted-by":"crossref","first-page":"8140","DOI":"10.1021\/bi00083a012","article-title":"Specificity studies of heparin lyases from Flavobacterium heparinum","volume":"32","author":"Desai","year":"1993","journal-title":"Biochemistry"},{"key":"10.1016\/j.carbpol.2024.122216_bb0190","doi-asserted-by":"crossref","first-page":"10309","DOI":"10.1021\/jacs.9b03266","article-title":"An efficient modular one-pot synthesis of heparin-based anticoagulant idraparinux","volume":"141","author":"Dey","year":"2019","journal-title":"Journal of the American Chemical Society"},{"issue":"12","key":"10.1016\/j.carbpol.2024.122216_bb0195","doi-asserted-by":"crossref","first-page":"4638","DOI":"10.1021\/acs.orglett.0c01386","article-title":"Programmable one-pot synthesis of heparin pentasaccharide fondaparinux","volume":"22","author":"Dey","year":"2020","journal-title":"Organic Letter"},{"issue":"7","key":"10.1016\/j.carbpol.2024.122216_bb0200","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1517\/17425255.2013.794787","article-title":"Certoparin for the treatment and prevention of thrombosis: Pharmacological profile and results from clinical studies","volume":"9","author":"Donadini","year":"2013","journal-title":"Expert Opinion on Drug Metabolism & Toxicology"},{"issue":"14","key":"10.1016\/j.carbpol.2024.122216_bb0205","article-title":"Synthesis of bioengineered heparin and enoxaparin chemically and biologically equivalent similar to the porcine-derived products and convertible to low molecular weight heparin","volume":"121","author":"Douaisi","year":"2024","journal-title":"Proceedings of the National Academies of Science (USA)"},{"issue":"9","key":"10.1016\/j.carbpol.2024.122216_bb0210","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1007\/s13361-018-1969-z","article-title":"An automated, high-throughput for interpreting the tandem mass spectra of glycosaminoglycan","volume":"29","author":"Duan","year":"2018","journal-title":"Journal of the American Society for Mass Spectrometry"},{"key":"10.1016\/j.carbpol.2024.122216_bb0215","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/bs.accb.2021.11.003","article-title":"Strategies in synthesis of heparin\/heparan sulfate oligosaccharides: 2000\u2013present","volume":"80","author":"Dulaney","year":"2021","journal-title":"Advances in Carbohydrate Chemistry and Biochemistry"},{"issue":"12","key":"10.1016\/j.carbpol.2024.122216_bb0220","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.2165\/00003088-200342120-00003","article-title":"Pharmacodynamic and pharmacokinetic properties of enoxaparin: Implications for clinical practice","volume":"42","author":"Fareed","year":"2003","journal-title":"Clinical Pharmacokinetics"},{"issue":"4","key":"10.1016\/j.carbpol.2024.122216_bb0225","doi-asserted-by":"crossref","first-page":"652","DOI":"10.2165\/00003495-199447040-00007","article-title":"A review of its pharmacology, and clinical application in the prevention and treatment of thromboembolic and other vascular disorders","volume":"47","author":"Frampton","year":"1994","journal-title":"Drugs"},{"key":"10.1016\/j.carbpol.2024.122216_bb0230","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.addr.2015.11.002","article-title":"Bioengineered heparins and heparan sulfate","volume":"97","author":"Fu","year":"2016","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"5","key":"10.1016\/j.carbpol.2024.122216_bb0235","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/jps.23939","article-title":"Structure and activity of a new low-molecular-weight heparin produced by enzymatic ultrafiltration","volume":"103","author":"Fu","year":"2014","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.carbpol.2024.122216_bb0240","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.chroma.2013.02.013","article-title":"Novel reverse-phase ion pair-high performance liquid chromatography separation of heparin, heparan sulfate and low molecular weight-heparins disaccharides and oligosaccharides","volume":"1284","author":"Galeotti","year":"2013","journal-title":"Journal of Chromatography A"},{"issue":"5","key":"10.1016\/j.carbpol.2024.122216_bb0245","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/00062752-200209000-00006","article-title":"Heparin pentasaccharide","volume":"9","author":"Gallus","year":"2002","journal-title":"Current Opinion in Hematology"},{"key":"10.1016\/j.carbpol.2024.122216_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.118554","article-title":"Saturated tetrasaccharide profile of enoxaparin. An additional piece to the heparin biosynthesis puzzle","volume":"273","author":"Gardini","year":"2021","journal-title":"Carbohydrate Polymers"},{"key":"10.1016\/j.carbpol.2024.122216_bb0255","doi-asserted-by":"crossref","first-page":"7539","DOI":"10.1021\/ac3016054","article-title":"Mass spectrometric method for determining the uronic acid epimerization in heparan sulfate disaccharides generated using nitrous acid","volume":"84","author":"Gill","year":"2012","journal-title":"Analytical Chemistry"},{"key":"10.1016\/j.carbpol.2024.122216_bb0260","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3389\/fmed.2018.00341","article-title":"Recombinant heparin-new opportunities","volume":"5","author":"Glass","year":"2018","journal-title":"Frontier in Medicine"},{"key":"10.1016\/j.carbpol.2024.122216_bb0265","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1021\/acs.orglett.7b03340","article-title":"Photoswitchable heparinase III for enzymatic preparation of low molecular weight heparin","volume":"20","author":"Gu","year":"2018","journal-title":"Organic Letters"},{"key":"10.1016\/j.carbpol.2024.122216_bb0270","doi-asserted-by":"crossref","first-page":"9325","DOI":"10.1039\/C4RA09854D","article-title":"Solid-phase assembly of glycosaminoglycan oligosaccharide precursors","volume":"5","author":"Guedes","year":"2015","journal-title":"RSC Advances"},{"issue":"6","key":"10.1016\/j.carbpol.2024.122216_bb0275","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nbt1407","article-title":"Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events","volume":"26","author":"Guerrini","year":"2008","journal-title":"Nature Biotechnology"},{"key":"10.1016\/j.carbpol.2024.122216_bb0280","doi-asserted-by":"crossref","first-page":"8275","DOI":"10.1021\/acs.analchem.5b01366","article-title":"Differentiation of generic enoxaparins marketed in the United States by employing NMR and multivariate analysis","volume":"87","author":"Guerrini","year":"2015","journal-title":"Analytical Chemistry"},{"issue":"3","key":"10.1016\/j.carbpol.2024.122216_bb0285","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1021\/acs.jmedchem.2c02118","article-title":"Design of an ultralow molecular weight heparin that resists heparinase biodegradation","volume":"66","author":"Ham","year":"2023","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.carbpol.2024.122216_bb0290","doi-asserted-by":"crossref","first-page":"6158","DOI":"10.1039\/C5SC02091C","article-title":"Making the longest sugars: A chemical synthesis of heparin-related [4]n oligosaccharides from 16-mer to 40-mer","volume":"6","author":"Hansen","year":"2015","journal-title":"Chemical Science"},{"key":"10.1016\/j.carbpol.2024.122216_bb0295","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/bs.pmbts.2019.02.003","article-title":"Low molecular weight heparins and their clinical applications","volume":"163","author":"Hao","year":"2019","journal-title":"Progress in Molecular Biology and Translational Science"},{"key":"10.1016\/j.carbpol.2024.122216_bb0300","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/j.carbpol.2011.09.087","article-title":"Photochemical preparation of a novel low molecular weight heparin","volume":"87","author":"Higashi","year":"2012","journal-title":"Carbohydrate Polymers"},{"key":"10.1016\/j.carbpol.2024.122216_bb0305","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1124\/pharmrev.122.000684","article-title":"Pharmacology of heparin and related drugs: An update","volume":"75","author":"Hogwood","year":"2023","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.carbpol.2024.122216_bb0310","doi-asserted-by":"crossref","first-page":"4733","DOI":"10.1182\/blood.V126.23.4733.4733","article-title":"Resourcing of heparin and low molecular weight heparins from bovine, ovine, and porcine origin. Studies to demonstrate the biosimilarities","volume":"126","author":"Hoppensteadt","year":"2015","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.carbpol.2024.122216_bb0315","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1074\/mcp.M114.039560","article-title":"A computational framework for heparan sulfate sequencing using high-resolution tandem mass spectra","volume":"13","author":"Hu","year":"2014","journal-title":"Molecular & Cellular Proteomics: MCP"},{"issue":"2","key":"10.1016\/j.carbpol.2024.122216_bb0320","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s12247-022-09665-7","article-title":"Commercial low molecular weight heparins\u2014Patent ecosystem and technology paradigm for quality characterization","volume":"18","author":"Iqbal","year":"2023","journal-title":"Journal of Pharmaceutical Innovation"},{"issue":"2","key":"10.1016\/j.carbpol.2024.122216_bb0325","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1055\/s-2007-1000396","article-title":"Pharmacologic profile of a low-molecular-weight heparin depolymerized by gamma-irradiation","volume":"21","author":"Jeske","year":"1995","journal-title":"Seminars in Thrombosis and Hemostasis"},{"key":"10.1016\/j.carbpol.2024.122216_bb0330","doi-asserted-by":"crossref","first-page":"150S","DOI":"10.1177\/1076029618798956","article-title":"Comparative pharmacokinetic profile of 3 batches of ovine low-molecular-weight heparin and 1 batch of branded enoxaparin","volume":"24","author":"Jeske","year":"2018","journal-title":"Clinical and Applied Thrombosis\/Hemostasis"},{"key":"10.1016\/j.carbpol.2024.122216_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.114472","article-title":"Quality control and product differentiation of LMWHs marketed in China using 1H NMR spectroscopy and chemometric tools","volume":"209","author":"Jiang","year":"2022","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"key":"10.1016\/j.carbpol.2024.122216_bb0340","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1039\/C9QO00480G","article-title":"Preactivation-based, iterative one-pot synthesis of anticoagulant pentasaccharide fondaparinux sodium","volume":"6","author":"Jin","year":"2019","journal-title":"Organic Chemistry Frontiers"},{"key":"10.1016\/j.carbpol.2024.122216_bb0345","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s43393-020-00011-x","article-title":"Bioengineered production of glycosaminoglycans and their analogues","volume":"1","author":"Jin","year":"2021","journal-title":"Systems Microbiology and Biomanufacturing"},{"key":"10.1016\/j.carbpol.2024.122216_bb0350","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/oxfordjournals.jbchem.a021928","article-title":"Disaccharide analysis of heparin and heparan sulfate using deaminative cleavage with nitrous acid and subsequent labeling with paranitrophenyl hydrazine","volume":"123","author":"Kariya","year":"1998","journal-title":"Journal of Biochemistry"},{"key":"10.1016\/j.carbpol.2024.122216_bb0355","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.2165\/00003495-200262110-00007","article-title":"Fondaparinux Sodium","volume":"62","author":"Keam","year":"2002","journal-title":"Drugs"},{"key":"10.1016\/j.carbpol.2024.122216_bb0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/10760296211005544","article-title":"Protamine sulfate neutralization profile of various dosages of bovine, ovine and porcine UFHs and their depolymerized derivatives in non-human primates","volume":"27","author":"Kouta","year":"2021","journal-title":"Clinical and Applied Thrombosis\/Hemostasis"},{"key":"10.1016\/j.carbpol.2024.122216_bb0365","doi-asserted-by":"crossref","DOI":"10.1177\/1076029619889406","article-title":"Comparative pharmacological profiles of various bovine, ovine, and porcine heparins","volume":"25","author":"Kouta","year":"2019","journal-title":"Clinical and Applied Thrombosis\/Hemostasis"},{"key":"10.1016\/j.carbpol.2024.122216_bb0370","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1038\/nbt885","article-title":"Enzymatic synthesis of antithrombin III-binding heparan sulfate pentasaccharide","volume":"21","author":"Kuberan","year":"2003","journal-title":"Nature Biotechnology"},{"key":"10.1016\/j.carbpol.2024.122216_bb0375","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41421-020-00192-8","article-title":"Sulfated polysaccharides effectively inhibit SARS-CoV-2 in vitro","volume":"6","author":"Kwon","year":"2020","journal-title":"Cell Discovery"},{"key":"10.1016\/j.carbpol.2024.122216_bb0380","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1021\/ac3032788","article-title":"Characterizing the microstructure of heparin and heparan sulfate using N-sulfoglucosamine 1H and 15N NMR chemical shift analysis","volume":"85","author":"Langeslay","year":"2013","journal-title":"Analytical Chemistry"},{"key":"10.1016\/j.carbpol.2024.122216_bb0385","doi-asserted-by":"crossref","first-page":"8006","DOI":"10.1021\/ac202144m","article-title":"Detection of the 1H and 15N NMR resonances of sulfamate groups in aqueous solution: A new tool for heparin and heparan sulfate characterization","volume":"83","author":"Langeslay","year":"2011","journal-title":"Analytical Chemistry"},{"issue":"3","key":"10.1016\/j.carbpol.2024.122216_bb0390","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nbt.2528","article-title":"Scientific considerations in the review and approval of generic enoxaparin in the United States","volume":"31","author":"Lee","year":"2013","journal-title":"Nature Biotechnology"},{"key":"10.1016\/j.carbpol.2024.122216_bb0395","series-title":"Heparin-A century of progress","author":"Lever","year":"2012"},{"issue":"13","key":"10.1016\/j.carbpol.2024.122216_bb0400","doi-asserted-by":"crossref","first-page":"6626","DOI":"10.1021\/ac501301v","article-title":"Bottom-up low molecular weight heparin analysis using liquid chromatography-Fourier transform mass spectrometry for extensive characterization","volume":"86","author":"Li","year":"2014","journal-title":"Analytical Chemistry"},{"key":"10.1016\/j.carbpol.2024.122216_bb0405","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ab.2014.02.033","article-title":"Analysis of 3-O-sulfo group-containing heparin tetrasaccharides in heparin by liquid chromatography-mass spectrometry","volume":"455","author":"Li","year":"2014","journal-title":"Analytical Biochemistry"},{"key":"10.1016\/j.carbpol.2024.122216_bb0410","doi-asserted-by":"crossref","first-page":"8822","DOI":"10.1021\/ac302232c","article-title":"Top-down approach for the direct characterization of low molecular weight heparins using LC-FT-MS","volume":"84","author":"Li","year":"2012","journal-title":"Analytical Chemistry"},{"key":"10.1016\/j.carbpol.2024.122216_bb0415","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/cmdc.201400019","article-title":"Total synthesis of anticoagulant pentasaccharide Fondaparinux","volume":"9","author":"Li","year":"2014","journal-title":"ChemMedChem"},{"key":"10.1016\/j.carbpol.2024.122216_bb0420","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nsmb811","article-title":"Structure of the antithrombin-thrombin-heparin ternary complex reveals the antithrombotic mechanism of heparin","volume":"11","author":"Li","year":"2004","journal-title":"Nature Structural & Molecular Biology"},{"key":"10.1016\/j.carbpol.2024.122216_bb0425","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00216-016-9662-1","article-title":"Analysis of heparin oligosaccharides by capillary electrophoresis-negative-ion electrospray ionization mass spectrometry","volume":"409","author":"Lin","year":"2017","journal-title":"Analytical and Bioanalytical Chemistry"},{"key":"10.1016\/j.carbpol.2024.122216_bb0430","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1073\/pnas.76.7.3198","article-title":"Structure of the antithrombin-binding site in heparin","volume":"76","author":"Lindahl","year":"1979","journal-title":"PNAS"},{"issue":"3","key":"10.1016\/j.carbpol.2024.122216_bb0435","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1039\/b819896a","article-title":"Lessons learned from the contamination heparin","volume":"26","author":"Liu","year":"2009","journal-title":"Natural Product Reports"},{"issue":"12","key":"10.1016\/j.carbpol.2024.122216_bb0440","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1039\/C4NP00076E","article-title":"Chemoenzymatic synthesis of heparan sulfate and heparin","volume":"31","author":"Liu","year":"2014","journal-title":"Natural Product Reports"},{"issue":"6","key":"10.1016\/j.carbpol.2024.122216_bb0445","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1177\/1076029616686422","article-title":"Comparison of low-molecular-weight heparins prepared from bovine heparins with enoxaparin","volume":"23","author":"Liu","year":"2017","journal-title":"Clinical and Applied Thrombosis\/Hemostasis"},{"key":"10.1016\/j.carbpol.2024.122216_bb0450","doi-asserted-by":"crossref","first-page":"W261","DOI":"10.1093\/nar\/gkh392","article-title":"GlycoFragment and GlycoSearchMS: Web tools to support the interpretation of mass spectra of complex carbohydrate","volume":"32","author":"Lohmann","year":"2004","journal-title":"Nucleic Acids Research"},{"key":"10.1016\/j.carbpol.2024.122216_bb0455","doi-asserted-by":"crossref","first-page":"24347","DOI":"10.1016\/S0021-9258(18)35772-7","article-title":"Purification and characterization of heparin lyases from Flavobacterium heparinum","volume":"267","author":"Lohse","year":"1992","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.carbpol.2024.122216_bb0460","unstructured":"Lopez, L. L. (1991). Depolymerization method of heparin. US Patent, 4981955."},{"key":"10.1016\/j.carbpol.2024.122216_bb0465","unstructured":"Lormeau, J. C., Petitou, M., & Choay, J. (1991). Method for obtaining biologically active mucopolysaccharides of high purity, by controlled depolymerization of heparin. US Patent, 5019649."},{"issue":"8","key":"10.1016\/j.carbpol.2024.122216_bb0470","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1182\/blood-2005-04-1546","article-title":"Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: A meta-analysis","volume":"106","author":"Martel","year":"2005","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.carbpol.2024.122216_bb0475","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.carres.2006.12.010","article-title":"Characterization of di- and monosulfated, unsaturated heparin disaccharides with terminal N-sulfated 1,6-anhydro-\u03b2-D-glucosamine or N-sulfated 1,6-anhydro-\u03b2-D-mannosamine residues","volume":"342","author":"Mascellani","year":"2007","journal-title":"Carbohydrate Research"},{"key":"10.1016\/j.carbpol.2024.122216_bb0480","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jpba.2016.12.031","article-title":"Qualification of HSQC methods for quantitative composition of heparin and low molecular weight heparins","volume":"136","author":"Mauri","year":"2017","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"issue":"9","key":"10.1016\/j.carbpol.2024.122216_bb0485","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045474","article-title":"GlycReSoft: A software package for automated recognition of glycans from LC\/MS data","volume":"7","author":"Maxwell","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.carbpol.2024.122216_bb0490","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1152\/ajplegacy.1916.41.2.250","article-title":"The thromboplastic action of cephalin","volume":"41","author":"McLean","year":"1916","journal-title":"American Journal of Physiology"},{"issue":"14","key":"10.1016\/j.carbpol.2024.122216_bb0495","doi-asserted-by":"crossref","first-page":"8193","DOI":"10.1021\/acs.chemrev.6b00010","article-title":"Chemical synthesis of glycosaminoglycans","volume":"116","author":"Mende","year":"2016","journal-title":"Chemical Reviews"},{"key":"10.1016\/j.carbpol.2024.122216_bb0500","first-page":"95","article-title":"Pharmacological and clinical differences between low-molecular-weight heparins: Implications for prescribing practice and therapeutic interchange","volume":"35","author":"Merli","year":"2010","journal-title":"P & T."},{"issue":"5\u20136","key":"10.1016\/j.carbpol.2024.122216_bb0505","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.drudis.2012.11.002","article-title":"Low molecular weight heparins copies: Are they considered to be generics or biosimilars","volume":"18","author":"Minghetti","year":"2013","journal-title":"Drug Discovery Today"},{"key":"10.1016\/j.carbpol.2024.122216_bb0510","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jpba.2017.10.020","article-title":"Authentication of animal origin of heparin and low molecular weight heparin including ovine, porcine and bovine species using 1D NMR spectroscopy and chemometric tools","volume":"149","author":"Monakhova","year":"2018","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"key":"10.1016\/j.carbpol.2024.122216_bb0515","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jpba.2016.07.033","article-title":"Analytical comparison of a US generic enoxaparin with the originator product: The focus on comparative assessment of antithrombin-binding components","volume":"129","author":"Mourier","year":"2016","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"key":"10.1016\/j.carbpol.2024.122216_bb0520","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ab.2004.06.020","article-title":"Chromatographic analysis and sequencing approach of heparin oligosaccharides using cetyltrimethylammonium dynamically coated stationary phase","volume":"332","author":"Mourier","year":"2004","journal-title":"Analytical Biochemistry"},{"issue":"3","key":"10.1016\/j.carbpol.2024.122216_bb0525","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1527-3466.2002.tb00087.x","article-title":"The low molecular weight heparin, tinzaparin, in thrombosis and beyond","volume":"20","author":"Mousa","year":"2002","journal-title":"Cardiovascular Drug Reviews"},{"key":"10.1016\/j.carbpol.2024.122216_bb0530","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1124\/pr.115.011247","article-title":"Pharmacology of heparin and related drugs","volume":"68","author":"Mulloy","year":"2016","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.carbpol.2024.122216_bb0535","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijbiomac.2020.05.159","article-title":"Production and characterization of low molecular weight heparosan in Bacillus megaterium using Escherichia coli K5 glycosyltransferases","volume":"160","author":"Nehru","year":"2020","journal-title":"International Journal of Biological Macromolecules"},{"key":"10.1016\/j.carbpol.2024.122216_bb0540","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41420-019-0188-0","article-title":"Platelet factor 4-containing immune complexes induce platelet activation followed by calpain-dependent platelet death","volume":"5","author":"Nevzorova","year":"2019","journal-title":"Cell Death Discovery"},{"issue":"4","key":"10.1016\/j.carbpol.2024.122216_bb0545","doi-asserted-by":"crossref","first-page":"e309","DOI":"10.1055\/a-1946-0325","article-title":"Anticoagulant activity of heparins from different animal sources are driven by a synergistic combination of physical-chemical factors","volume":"6","author":"Oliveira","year":"2022","journal-title":"TH Open"},{"key":"10.1016\/j.carbpol.2024.122216_bb0550","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/10760296231163251","article-title":"Potency adjusted blended heparin of bovine, ovine, and porcine heparin exhibit comparable biologic effects to referenced single-sourced porcine heparin","volume":"29","author":"Olson","year":"2023","journal-title":"Clinical and Applied Thrombosis\/Hemostasis"},{"key":"10.1016\/j.carbpol.2024.122216_bb0555","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.2741\/4462","article-title":"Heparin and anticoagulation","volume":"21","author":"Onishi","year":"2016","journal-title":"Frontier in Bioscience"},{"key":"10.1016\/j.carbpol.2024.122216_bb0560","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1021\/acs.analchem.8b03500","article-title":"Negative-ion mode capillary isoelectric focusing mass spectrometry for charge-based separation of acidic oligosaccharides","volume":"91","author":"Ouyang","year":"2019","journal-title":"Analytical Chemistry"},{"key":"10.1016\/j.carbpol.2024.122216_bb0565","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.chroma.2017.09.040","article-title":"Qualitative and quantitative analysis of heparin and low molecular weight heparins using size exclusion chromatography with multiple angle laser scattering\/refractive index and inductively coupled plasma\/mass spectrometry detectors","volume":"1522","author":"Ouyang","year":"2017","journal-title":"Journal of Chromatography A"},{"key":"10.1016\/j.carbpol.2024.122216_bb0570","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1007\/s00216-012-6045-0","article-title":"Structural elucidation of the tetrasaccharide pool in enoxaparin sodium","volume":"403","author":"Ozug","year":"2012","journal-title":"Analytical and Bioanalytical Chemistry"},{"issue":"2","key":"10.1016\/j.carbpol.2024.122216_bb0575","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1385\/ABAB:126:2:079","article-title":"Surface plasmon resonance: Applications in understanding receptor-ligand interaction","volume":"126","author":"Pattnaik","year":"2005","journal-title":"Applied Biochemistry and Biotechnology"},{"key":"10.1016\/j.carbpol.2024.122216_bb0580","unstructured":"Petitou, M., Jacquinet, J. C., Sinay, P., Choay, J., Lormeau, J. C., & Nassr, M. (1989). Process for the organic synthesis of oligosaccharides and derivatives thereof. U. S. Patent, 4818816."},{"key":"10.1016\/j.carbpol.2024.122216_bb0585","first-page":"215","article-title":"Dalteparin: Pharmacological properties and clinical efficacy in the prophylaxis and treatment of thromboembolic diseases","volume":"9","author":"Pineo","year":"2004","journal-title":"European Journal of Medical Research"},{"issue":"5","key":"10.1016\/j.carbpol.2024.122216_bb0590","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1089\/jop.2012.0012","article-title":"Subcutaneous nadroparin calcium in the treatment of recent onset retinal vein occlusion: A pilot study","volume":"28","author":"Pinna","year":"2012","journal-title":"Journal of Ocular Pharmacology and Therapeutics"},{"key":"10.1016\/j.carbpol.2024.122216_bb0595","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3390\/ph9030058","article-title":"1H and 15N NMR analyses on heparin, heparan sulfates and related monosaccharides concerning the chemical exchange regime of the N-sulfo-glucosamine sulfamate proton","volume":"9","author":"Pomin","year":"2016","journal-title":"Pharmaceuticals"},{"issue":"11","key":"10.1016\/j.carbpol.2024.122216_bb0600","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1002\/tcr.202100173","article-title":"Developments in the chemical synthesis of heparin and heparan sulfate","volume":"21","author":"Pongener","year":"2021","journal-title":"The Chemical Record"},{"key":"10.1016\/j.carbpol.2024.122216_bb0610","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0008-6215(90)84209-D","article-title":"Base-catalyzed conversion of the \u03b1-L-iduronic acid 2-sulfate unit of heparin into a unit of \u03b1-L-galacturonic acid, and related reactions","volume":"200","author":"Rej","year":"1990","journal-title":"Carbohydrate Research"},{"key":"10.1016\/j.carbpol.2024.122216_bb0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2020.129765","article-title":"Metabolic engineering of non-pathogenic Escherichia coli strains for the controlled production of low molecular weight heparosan and size-specific heparosan oligosaccharides","volume":"1865","author":"Roy","year":"2021","journal-title":"BBA-General Subjects"},{"issue":"21","key":"10.1016\/j.carbpol.2024.122216_bb0620","doi-asserted-by":"crossref","first-page":"5955","DOI":"10.1182\/blood-2012-01-406801","article-title":"Rational design and characterization of platelet factor 4 antagonists for the study of heparin-induced thrombocytopenia","volume":"119","author":"Sachais","year":"2012","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.carbpol.2024.122216_bb0625","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1002\/jssc.202000164","article-title":"Qualitative analysis of enzymatic and chemical depolymerized low molecular weight heparins by UHPLC coupled with electrospray ionization quadrupole time-of-flight-mass spectrometry","volume":"43","author":"Sadowski","year":"2020","journal-title":"Journal of Separation Science"},{"key":"10.1016\/j.carbpol.2024.122216_bb0630","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.5740\/jaoacint.17-0217","article-title":"Characterization of low-molecular-weight heparins by strong anion-exchange chromatography","volume":"100","author":"Sadowski","year":"2017","journal-title":"Journal of AOAC International"},{"issue":"15","key":"10.1016\/j.carbpol.2024.122216_bb0635","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1056\/NEJM198610093151509","article-title":"Low-molecular-weight heparin: Is small beautiful?","volume":"315","author":"Salzman","year":"1986","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.carbpol.2024.122216_bb0640","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2165\/1158581-S0-000000000-00000","article-title":"Bemiparin: pharmacological profile","volume":"70","author":"S\u00e1nchez-Ferrer","year":"2010","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.carbpol.2024.122216_bb0645","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S1367-5931(00)00145-9","article-title":"Heparin and heparan sulfate: Biosynthesis, structure and function","volume":"4","author":"Sasisekharan","year":"2000","journal-title":"Current Opinion in Chemical Biology"},{"issue":"4","key":"10.1016\/j.carbpol.2024.122216_bb0650","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.979","article-title":"Bioequivalence of a biosimilar enoxaparin (Cloti-XaTM) and its innovator (Clexane\u00ae): A single-dose, randomized, double-blind, two-period, two-treatment, two-sequence, crossover, balanced study in healthy human subjects","volume":"10","author":"Saxena","year":"2022","journal-title":"Pharmacology Research & Perspectives"},{"issue":"6","key":"10.1016\/j.carbpol.2024.122216_bb0655","doi-asserted-by":"crossref","first-page":"e764","DOI":"10.1097\/MJT.0000000000001191","article-title":"Porcine heparin shortages urge bovine heparin comeback: A literature review comparison of unfractionated heparin","volume":"29","author":"Sharma","year":"2022","journal-title":"American Journal of Therapeutical"},{"key":"10.1016\/j.carbpol.2024.122216_bb0660","doi-asserted-by":"crossref","first-page":"20051","DOI":"10.1074\/jbc.M110.101071","article-title":"Catalytic mechanism of heparinase II revealed by site-directed multagenesis and the crystal structure with its substrate","volume":"285","author":"Shaya","year":"2010","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.carbpol.2024.122216_bb0665","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijbiomac.2019.04.019","article-title":"Development of low molecular weight heparin by H2O2\/ascorbic acid with ultrasonic power and its anti-metastasis property","volume":"133","author":"Shen","year":"2019","journal-title":"International Journal of Biological Macromolecules"},{"key":"10.1016\/j.carbpol.2024.122216_bb0670","doi-asserted-by":"crossref","first-page":"13987","DOI":"10.1021\/acs.analchem.2c03267","article-title":"A cluster sequencing strategy to determine the consensus affinity domains in heparin for its binding to specific proteins","volume":"94","author":"Shi","year":"2022","journal-title":"Analytical Chemistry"},{"issue":"12","key":"10.1016\/j.carbpol.2024.122216_bb0675","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1016\/j.jtha.2023.08.020","article-title":"New insights into the binding of PF4 to long heparin oligosaccharides in ultralarge complexes using mass spectrometry","volume":"21","author":"Shi","year":"2023","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1016\/j.carbpol.2024.122216_bb0680","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2019.100613","article-title":"From unfractionated heparin to pentasaccharide: Paradigm of rigorous science growing in the understanding of the in vivo thrombin generation","volume":"39","author":"Spadarella","year":"2020","journal-title":"Blood Reviews"},{"key":"10.1016\/j.carbpol.2024.122216_bb0685","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.carbpol.2015.08.001","article-title":"Production of a low molecular weight heparin production using recombinant glycuronidase","volume":"134","author":"Su","year":"2015","journal-title":"Carbohydrate Polymers"},{"key":"10.1016\/j.carbpol.2024.122216_bb0690","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202211112","article-title":"Chemoenzymatic synthesis of heparin sulfate oligosaccharides having a domain structure","volume":"61","author":"Sun","year":"2022","journal-title":"Angewandte Chemie International Edition"},{"key":"10.1016\/j.carbpol.2024.122216_bb0695","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1021\/acs.analchem.5b04405","article-title":"Capillary electrophoresis-mass spectrometry for the analysis of heparin oligosaccharides and low molecular weight heparin","volume":"88","author":"Sun","year":"2016","journal-title":"Analytical Chemistry"},{"issue":"15","key":"10.1016\/j.carbpol.2024.122216_bb0700","doi-asserted-by":"crossref","first-page":"7738","DOI":"10.1021\/acs.analchem.6b01709","article-title":"Comprehensive identification and quantitation of basic building blocks for low-molecular weight heparin","volume":"88","author":"Sun","year":"2016","journal-title":"Analytical Chemistry"},{"issue":"11","key":"10.1016\/j.carbpol.2024.122216_bb0705","article-title":"Diversifying the global heparin supply chain: Reintroduction of bovine heparin in the United States?","volume":"39","author":"Szajek","year":"2015","journal-title":"Pharmaceutical Technology"},{"key":"10.1016\/j.carbpol.2024.122216_bb0710","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ymben.2022.01.002","article-title":"Multiplex genome editing of mammalian cells for producing recombinant heparin","volume":"70","author":"Thacker","year":"2022","journal-title":"Metabolic Engineering"},{"key":"10.1016\/j.carbpol.2024.122216_bb0715","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/1756-0500-6-230","article-title":"Bovine and porcine heparins: Different drugs with similar effects on human haemodialysis","volume":"6","author":"Tovar","year":"2013","journal-title":"BMC Research Notes"},{"issue":"2","key":"10.1016\/j.carbpol.2024.122216_bb0720","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1055\/s-0038-1657644","volume":"78","author":"Troy","year":"1997","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1016\/j.carbpol.2024.122216_bb0725","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s11094-018-1776-7","article-title":"Preparation of low-molecular-weight heparins by radiation-induced destruction","volume":"52","author":"Tuaeva","year":"2018","journal-title":"Pharmaceutical Chemistry Journal"},{"key":"10.1016\/j.carbpol.2024.122216_bb0730","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/bj2770297","article-title":"Sequence analysis of heparin sulphate indicates defined location of N-sulphated glucosamine and iduronate 2-sulphate residues proximal to the protein-linkage region","volume":"277","author":"Turbbull","year":"1991","journal-title":"The Biochemistry Journal"},{"key":"10.1016\/j.carbpol.2024.122216_bb0740","series-title":"USP monographs, enoxaparin sodium. USP-NF","author":"United States Pharmacopeia","year":"2023"},{"key":"10.1016\/j.carbpol.2024.122216_bb0745","unstructured":"Uzan, A. (1998). Sulfated polysaccharides obtained from heparin, preparation process, pharmaceutical composition and use thereof. US Patent, 5849721."},{"key":"10.1016\/j.carbpol.2024.122216_bb0750","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/btm2.10042","article-title":"Engineered heparins as new anticoagulant drugs","volume":"2","author":"Vaidyanathan","year":"2017","journal-title":"Bioengineering & Translational Medicine"},{"key":"10.1016\/j.carbpol.2024.122216_bb0755","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/jth.14372","article-title":"Imminent risk of a global shortage of heparin caused by the African swine fever afflicting the Chinese pig herd","volume":"17","author":"Vilanova","year":"2019","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1016\/j.carbpol.2024.122216_bb0760","article-title":"HepParser: An intelligent software program for deciphering low-molecular-weight heparin based on mass spectrometry","volume":"9","author":"Wang","year":"2021","journal-title":"Frontiers in Chemistry"},{"key":"10.1016\/j.carbpol.2024.122216_bb0765","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/s41557-023-01248-4","article-title":"Efficient platform for synthesizing comprehensive heparan sulfate oligosaccharides libraries for decoding glycosaminoglycan-protein interactions","volume":"15","author":"Wang","year":"2023","journal-title":"Nature Chemistry"},{"key":"10.1016\/j.carbpol.2024.122216_bb0770","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.119818","article-title":"Heparin: An old drug for new clinical applications","volume":"295","author":"Wang","year":"2022","journal-title":"Carbohydrate Polymers"},{"issue":"2","key":"10.1016\/j.carbpol.2024.122216_bb0775","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbapap.2019.140301","article-title":"Chemoenzymatic synthesis of ultralow and low-molecular weight heparins","volume":"1868","author":"Wang","year":"2020","journal-title":"Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics"},{"issue":"12","key":"10.1016\/j.carbpol.2024.122216_bb0780","article-title":"GlycComp-Soft: Software for automated comparison of low molecular weight heparins using top-down LC\/MS data","volume":"11","author":"Wang","year":"2016","journal-title":"PLoS One"},{"issue":"32","key":"10.1016\/j.carbpol.2024.122216_bb0785","doi-asserted-by":"crossref","first-page":"11191","DOI":"10.1021\/acs.analchem.1c01761","article-title":"Improving the sensitivity for quantifying heparan sulfate from biological samples","volume":"93","author":"Wang","year":"2021","journal-title":"Analytical Chemistry"},{"issue":"17","key":"10.1016\/j.carbpol.2024.122216_bb0790","doi-asserted-by":"crossref","first-page":"9311","DOI":"10.1073\/pnas.1920880117","article-title":"ZNF263 is a transcriptional regulator of heparin and heparan sulfate biosynthesis","volume":"117","author":"Weiss","year":"2020","journal-title":"PNAS"},{"key":"10.1016\/j.carbpol.2024.122216_bb0795","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1056\/NEJM199709043371007","article-title":"Low-molecular-weight heparins","author":"Weitz","year":"1997","journal-title":"The New England Journal of Medicine"},{"issue":"8","key":"10.1016\/j.carbpol.2024.122216_bb0800","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.2165\/00003495-200161080-00017","article-title":"Reviparin: A review of its efficacy in the prevention and treatment of venous thromboembolism","volume":"61","author":"Wellington","year":"2001","journal-title":"Drugs"},{"key":"10.1016\/j.carbpol.2024.122216_bb0805","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jpba.2018.11.018","volume":"164","author":"Wu","year":"2019","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"key":"10.1016\/j.carbpol.2024.122216_bb0810","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.carbpol.2013.09.052","article-title":"Controllable production of low molecular weight heparins by combinations of heparinase I\/II\/III","volume":"101","author":"Wu","year":"2014","journal-title":"Carbohydrate Polymers"},{"key":"10.1016\/j.carbpol.2024.122216_bb0815","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1021\/jm101381k","article-title":"Heparin mapping using heparin lyases and the generation of a novel low molecular weight heparin","volume":"54","author":"Xiao","year":"2011","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.carbpol.2024.122216_bb0820","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2023.464179","article-title":"MsPHep: An online application for low molecular weight heparin rapid characterization based on liquid chromatography-tandem mass spectrometry","volume":"1705","author":"Xie","year":"2023","journal-title":"Journal of Chromatography A"},{"key":"10.1016\/j.carbpol.2024.122216_bb0825","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.carbpol.2018.05.070","article-title":"Preparation of low molecular weight heparins from bovine and ovine heparins using nitrous acid degradation","volume":"197","author":"Xie","year":"2018","journal-title":"Carbohydrate Polymers"},{"key":"10.1016\/j.carbpol.2024.122216_bb0830","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.carbpol.2017.08.134","article-title":"An engineered platform based on chitin-affinity immobilization for producing low molecular weight heparin","volume":"177","author":"Xu","year":"2017","journal-title":"Carbohydrate Polymers"},{"issue":"4","key":"10.1016\/j.carbpol.2024.122216_bb0835","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nchembio.1459","article-title":"Homogeneous low-molecular-weight heparins with reversible anticoagulant activity","volume":"10","author":"Xu","year":"2014","journal-title":"Nature Chemical Biology"},{"issue":"406","key":"10.1016\/j.carbpol.2024.122216_bb0840","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan5954","article-title":"Synthetic oligosaccharides can replace animal-sourced low-molecular weight heparins","volume":"9","author":"Xu","year":"2017","journal-title":"Science Translational Medicine."},{"issue":"6055","key":"10.1016\/j.carbpol.2024.122216_bb0845","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1126\/science.1207478","article-title":"Chemoenzymatic synthesis of homogeneous ultralow molecular weight heparins","volume":"334","author":"Xu","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.carbpol.2024.122216_bb0850","doi-asserted-by":"crossref","first-page":"29054","DOI":"10.1074\/jbc.M112.358523","article-title":"Chemoenzymatic synthesis of heparin oligosaccharides with both anti-factor Xa and anti-factor IIa activity","volume":"287","author":"Xu","year":"2012","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.carbpol.2024.122216_bb0855","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jprot.2014.07.013","article-title":"Enhancing MSn mass spectrometry strategy for carbohydrate analysis: A b2 ion spectral library","volume":"112","author":"Xue","year":"2015","journal-title":"Journal of Proteomics"},{"key":"10.1016\/j.carbpol.2024.122216_bb0860","doi-asserted-by":"crossref","first-page":"13000","DOI":"10.1021\/acs.analchem.2c01579","article-title":"Glycan mapping of low-molecular-weight heparin using mass spectral correction based on chromatography fitting with \u201cGlycomapping\u201d software","volume":"94","author":"Yan","year":"2022","journal-title":"Analytical Chemistry"},{"key":"10.1016\/j.carbpol.2024.122216_bb0865","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ab.2011.04.003","article-title":"Ultra-performance ion-pairing liquid chromatography with on-line electrospray ion trap mass spectrometry for heparin disaccharide analysis","volume":"415","author":"Yang","year":"2011","journal-title":"Analytical Biochemistry"},{"key":"10.1016\/j.carbpol.2024.122216_bb0870","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.cplett.2018.08.019","article-title":"Depolymerization of heparin by dielectric barrier discharge: Effect of operating modes and anticoagulant potential analysis of low-molecular-weight heparin","volume":"708","author":"Yang","year":"2018","journal-title":"Chemical Physics Letters"},{"key":"10.1016\/j.carbpol.2024.122216_bb0875","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.119825","article-title":"Enzymatic synthesis of low molecular weight heparins from N-sulfo heparosan depolymerized by heparanase or heparin lyase","volume":"295","author":"Yu","year":"2022","journal-title":"Carbohydrate Polymers"},{"key":"10.1016\/j.carbpol.2024.122216_bb0880","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1021\/acschembio.1c00928","article-title":"Chemobiocatalytic synthesis of a low-molecular-weight heparin","volume":"17","author":"Yu","year":"2022","journal-title":"ACS Chemical Biology"},{"key":"10.1016\/j.carbpol.2024.122216_bb0885","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/glycob\/cwz039","article-title":"Specificity and action pattern of heparanase Bp, a \u03b2-glucuronidase from Burkholderia pseudomallei","volume":"29","author":"Yu","year":"2019","journal-title":"Glycobiology"},{"key":"10.1016\/j.carbpol.2024.122216_bb0890","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s11094-021-02414-z","article-title":"Molecular weight characteristics and anticoagulant activity of low-molecular-weight heparin obtained by nitrous acid depolymerization","volume":"55","author":"Yur\u2019eva","year":"2021","journal-title":"Pharmaceutical Chemistry Journal"},{"key":"10.1016\/j.carbpol.2024.122216_bb0895","doi-asserted-by":"crossref","first-page":"10654","DOI":"10.1021\/acs.analchem.6b03081","article-title":"Complete molecular weight profiling of low-molecular weight heparins using size exclusion chromatography-ion suppressor-high-resolution mass spectrometry","volume":"88","author":"Zaia","year":"2016","journal-title":"Analytical Chemistry"},{"key":"10.1016\/j.carbpol.2024.122216_bb0900","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.120303","article-title":"A quantitative mass spectrometry method to differentiate bovine and ovine heparins from pharmaceutical porcine heparin","volume":"301","author":"Zhang","year":"2023","journal-title":"Carbohydrate Polymers"},{"issue":"2","key":"10.1016\/j.carbpol.2024.122216_bb0905","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.xphs.2019.10.040","article-title":"Evaluating heparin products for heparin-induced thrombocytopenia using surface plasmon resonance","volume":"109","author":"Zhang","year":"2020","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.carbpol.2024.122216_bb0910","doi-asserted-by":"crossref","first-page":"8323","DOI":"10.1039\/D2OB01221A","article-title":"Facile chemoenzymatic synthesis of unmodified anticoagulant ultra-low molecular weight heparin","volume":"20","author":"Zhang","year":"2022","journal-title":"Organic & Biomolecular Chemistry"},{"key":"10.1016\/j.carbpol.2024.122216_bb0915","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jchromb.2017.08.047","article-title":"Quantitative analysis of antithrombin III binding site in low molecular weight heparins by exhausetive heparinases digestion and capillary electrophoresis","volume":"1068","author":"Zhang","year":"2017","journal-title":"Journal of Chromatography B"},{"key":"10.1016\/j.carbpol.2024.122216_bb0920","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/s41467-021-21441-8","article-title":"Discovery of exolytic heparinases and their catalytic mechanism and potential application","volume":"12","author":"Zhang","year":"2021","journal-title":"Nature Communications"},{"key":"10.1016\/j.carbpol.2024.122216_bb0925","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2019.115695","article-title":"Oligosaccharides mapping of nitrous acid degraded heparin through UHPLC-HILIC\/WAX-MS","volume":"231","author":"Zhang","year":"2020","journal-title":"Carbohydrate Polymers"},{"issue":"12","key":"10.1016\/j.carbpol.2024.122216_bb0930","doi-asserted-by":"crossref","first-page":"7932","DOI":"10.1039\/C7SC03541A","article-title":"Chemoenzymatic synthesis of heparan sulfate and heparin oligosaccharides and NMR analysis: Paving the way to a diverse library for glycobiologists","volume":"8","author":"Zhang","year":"2017","journal-title":"Chemical Science"},{"issue":"8","key":"10.1016\/j.carbpol.2024.122216_bb0935","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1039\/D1GC04672A","article-title":"Synthesis of bioengineered heparin by recombinant yeast Pichia pastoris","volume":"24","author":"Zhang","year":"2022","journal-title":"Green Chemistry"},{"key":"10.1016\/j.carbpol.2024.122216_bb0940","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/bs.pmbts.2019.02.004","article-title":"The clinical use of fondaparinux: A synthetic heparin pentasaccharide","volume":"163","author":"Zhang","year":"2019","journal-title":"Progress in Molecular Biology and Translational Science"},{"issue":"11","key":"10.1016\/j.carbpol.2024.122216_bb0945","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.1021\/ac9001707","article-title":"Quantification of heparan sulfate disaccharides using ion-pairing reversed-phase microflow high-performance liquid chromatography with electrospray ionization trap mass spectrometry","volume":"81","author":"Zhang","year":"2009","journal-title":"Analytical Chemistry"},{"key":"10.1016\/j.carbpol.2024.122216_bb0950","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.biopha.2016.02.021","article-title":"Preparation and evaluation a new generation of low molecular weight heparin","volume":"79","author":"Zhao","year":"2016","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"5","key":"10.1016\/j.carbpol.2024.122216_bb0955","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1002\/anie.201913029","article-title":"3-O-sulfation of heparan sulfate enhances tau interaction and cellular uptake","volume":"59","author":"Zhao","year":"2020","journal-title":"Angewandte Chemie International Edition"},{"key":"10.1016\/j.carbpol.2024.122216_bb0960","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ultsonch.2018.11.016","article-title":"Preparation of low molecular weight heparin using an ultrasound-assisted Fenton-system","volume":"52","author":"Zhi","year":"2019","journal-title":"Ultrasonics-Sonochemistry"}],"container-title":["Carbohydrate Polymers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0144861724004429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0144861724004429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T18:39:27Z","timestamp":1777487967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0144861724004429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":194,"alternative-id":["S0144861724004429"],"URL":"https:\/\/doi.org\/10.1016\/j.carbpol.2024.122216","relation":{},"ISSN":["0144-8617"],"issn-type":[{"value":"0144-8617","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality control, safety assessment and preparation approaches of low molecular weight heparin","name":"articletitle","label":"Article Title"},{"value":"Carbohydrate Polymers","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carbpol.2024.122216","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"122216"}}